Mardi Dier - Oct 12, 2022 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
CFO & Executive Vice President
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Oct 12, 2022
Transactions value $
-$133,158
Form type
4
Date filed
10/14/2022, 12:58 PM
Previous filing
Sep 19, 2022
Next filing
Oct 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale -$133K -3.48K -4.85% $38.22 68.3K Oct 12, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.